Qube Research & Technologies LTD Pfizer Inc Transaction History

Qube Research & Technologies LTD

$93.8 Billion
Q2 2025

A detailed history of Qube Research & Technologies LTD transactions in Pfizer Inc stock. As of the latest transaction made, Qube Research & Technologies LTD holds 3,139,200 shares of PFE stock, worth $77.4 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

3,139,200

Previous 10,711,578 70.69%

Holding current value

$77.4 Million

Previous $271 Million 71.97%

% of portfolio

0.08%

Previous 0.33%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$25.01 - $27.13 $268 Million - $291 Million	10,711,578 New	10,711,578 $271 Million
Q3 2024 Nov 14, 2024	BUY	$27.7 - $31.39 $31.2 Million - $35.4 Million	1,127,162 Added 4558.06%	1,151,891 $33.3 Million
Q2 2024 Aug 14, 2024	SELL	$25.26 - $29.6 $118 Million - $138 Million	-4,666,112 Reduced 99.47%	24,729 $691,000
Q1 2024 May 14, 2024	BUY	$25.89 - $29.73 $88.3 Million - $101 Million	3,411,743 Added 266.73%	4,690,841 $130 Million
Q4 2023 Feb 13, 2024	BUY	$26.13 - $33.94 $4.42 Million - $5.74 Million	169,012 Added 15.23%	1,279,098 $36.8 Million
Q3 2023 Nov 13, 2023	BUY	$32.09 - $37.51 $11.6 Million - $13.6 Million	362,717 Added 48.53%	1,110,086 $36.8 Million
Q2 2023 Aug 14, 2023	SELL	$36.12 - $41.79 $25.7 Million - $29.7 Million	-711,273 Reduced 48.76%	747,369 $27.4 Million
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $55 Million - $71.6 Million	1,396,976 Added 2265.39%	1,458,642 $59.5 Million
Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $40.2 Million - $52.5 Million	-964,039 Reduced 93.99%	61,666 $3.16 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $44.9 Million - $54.8 Million	1,025,705 New	1,025,705 $44.9 Million
Q2 2022 Aug 15, 2022	SELL	$46.53 - $55.17 $57.1 Million - $67.7 Million	-1,227,560 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$45.75 - $56.69 $49.5 Million - $61.4 Million	1,083,046 Added 749.44%	1,227,560 $63.6 Million
Q4 2021 Feb 01, 2022	SELL	$41.32 - $61.25 $23.8 Million - $35.3 Million	-576,163 Reduced 79.95%	144,514 $8.53 Million
Q3 2021 Nov 12, 2021	BUY	$39.25 - $50.42 $15.2 Million - $19.6 Million	387,877 Added 116.55%	720,677 $31 Million
Q2 2021 Aug 13, 2021	BUY	$35.91 - $40.68 $5.88 Million - $6.66 Million	163,692 Added 96.8%	332,800 $13 Million
Q1 2021 May 14, 2021	SELL	$33.49 - $37.77 $35 Million - $39.5 Million	-1,046,035 Reduced 86.08%	169,108 $6.13 Million
Q4 2020 Feb 16, 2021	BUY	$33.47 - $42.56 $28.8 Million - $36.7 Million	861,156 Added 243.27%	1,215,143 $44.7 Million
Q3 2020 Nov 12, 2020	BUY	$31.75 - $37.25 $8.22 Million - $9.64 Million	258,803 Added 271.9%	353,987 $13 Million
Q2 2020 Aug 14, 2020	BUY	$30.12 - $36.54 $2.87 Million - $3.48 Million	95,184 New	95,184 $3.11 Million
Q1 2020 May 15, 2020	SELL	$27.03 - $38.62 $739,351 - $1.06 Million	-27,353 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$32.92 - $37.36 $900,460 - $1.02 Million	27,353 New	27,353 $1.07 Million
Q3 2019 Nov 13, 2019	SELL	$32.49 - $42.13 $2.14 Million - $2.78 Million	-65,915 Closed	0 $0
Q2 2019 Aug 02, 2019	SELL	$36.98 - $41.52 $4.23 Million - $4.75 Million	-114,520 Reduced 63.47%	65,915 $2.86 Million
Q1 2019 May 15, 2019	BUY	$37.5 - $41.2 $6.28 Million - $6.9 Million	167,498 Added 1294.72%	180,435 $7.66 Million
Q4 2018 Feb 14, 2019	SELL	$38.47 - $43.86 $4.5 Million - $5.13 Million	-117,042 Reduced 90.05%	12,937 $565,000
Q3 2018 Nov 14, 2018	BUY	$34.47 - $41.81 $4.48 Million - $5.43 Million	129,979 New	129,979 $5.73 Million
Q2 2018 Aug 14, 2018	SELL	$32.98 - $35.16 $299,821 - $319,639	-9,091 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$31.91 - $37.02 $290,093 - $336,548	9,091 New	9,091 $322,000

Others Institutions Holding PFE

# of Institutions

3,312

Shares Held

3.65B

Call Options Held

96.5M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $138B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Account

Qube Research & Technologies LTD Pfizer Inc Transaction History